+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bacteriophage Market by Type, Product, Form, Delivery Mode, Application, End-User - Global Forecast 2025-2030- Product Image
Bacteriophage Market by Type, Product, Form, Delivery Mode, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Bacteriophage Market by Type, Product, Form, Delivery Mode, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6013748
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bacteriophage Market grew from USD 47.74 million in 2023 to USD 50.15 million in 2024. It is expected to continue growing at a CAGR of 5.26%, reaching USD 68.35 million by 2030.

Bacteriophages, viruses that specifically infect and lyse bacteria, have resurfaced as pivotal components in combating antibiotic-resistant infections, revolutionizing the medical and agricultural domains. The necessity is underpinned by the escalating antibiotic resistance crisis, where traditional antibiotics falter, presenting bacteriophages as a viable alternative due to their unique ability to target and eradicate specific bacterial strains while preserving beneficial microbiota. Applications predominantly span into antibacterial therapy, agriculture for the protection of crops and livestock, and biocontrol in various industries such as food processing. End-use sectors include hospitals, clinics, agricultural fields, and food safety management systems. Market growth is propelled by factors such as increased R&D investments, advancements in genomic and phage therapy technologies, and a growing trend towards sustainable agricultural practices. Potential opportunities lie in tailored phage therapy platforms, biopesticides for precision agriculture, and regulatory frameworks evolving to support phage applications globally. To harness these opportunities, stakeholders should invest in cross-sector partnerships and open innovation models to accelerate product development and market entry.

However, barriers such as the complexity of regulatory approvals, high R&D costs, and ecological concerns regarding phage application persist, potentially hindering swift market expansion. There's a crucial need for robust clinical trials, clear regulatory pathways, and public awareness to foster acceptance and trust in phage-based solutions. Areas of innovation primed for growth include synthetic biology to engineer highly specific phages, AI-driven phage selection and optimization, and development of robust delivery mechanisms tailored for personalized medicine and widespread agricultural use. As the market landscape is highly dynamic and competitive, businesses should focus on strategic collaborations and continuously adapt to technological breakthroughs to maintain a competitive edge. Consequently, while bacteriophages offer promising avenues for addressing global health and agricultural challenges, ensuring careful and strategic deployment is vital for sustainable market development.

Understanding Market Dynamics in the Bacteriophage Market

The Bacteriophage Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
    • Rising investments in research and development for bacteriophage applications in healthcare
    • Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
    • Expansion of bacteriophage application in food safety and agricultural productivity enhancement
  • Market Restraints
    • Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
    • High competition from established antibiotic treatments limiting bacteriophage therapy adoption
  • Market Opportunities
    • Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
    • Implementing bacteriophage use in veterinary medicine to improve animal health and food production
    • Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
  • Market Challenges
    • Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
    • High specificity of bacteriophages requiring individualized development for different bacterial strains

Exploring Porter’s Five Forces for the Bacteriophage Market

Porter’s Five Forces framework further strengthens the insights of the Bacteriophage Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Bacteriophage Market

External macro-environmental factors deeply influence the performance of the Bacteriophage Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Bacteriophage Market

The Bacteriophage Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Bacteriophage Market

The Bacteriophage Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Bacteriophage Market

The Bacteriophage Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bacteriophage Market, highlighting leading vendors and their innovative profiles. These include Adaptive Phage Therapeutics, AmpliPhi Biosciences Corporation, Armata Pharmaceuticals Inc., ContraFect Corporation, CYTOO S.A., Eligo Bioscience, EnBiotix Inc., Fixed-Phage Limited, Intralytix Inc., iNtRON Biotechnology, Locus Biosciences Inc., Micreos BV, Optipharm Co. Ltd., Phage International Inc., Phagelux Inc., Phagomed Biopharma GmbH, Pherecydes Pharma, Phico Therapeutics Ltd., Sexton Biotechnologies, and TechnoPhage SA.

Market Segmentation & Coverage

This research report categorizes the Bacteriophage Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Lysogenic
    • Lytic
  • Product
    • Phage Diagnostic Products
    • Phage Research Tools
    • Phage Therapy Products
  • Form
    • Liquid
    • Solid
  • Delivery Mode
    • Injectable
    • Oral
    • Topical
  • Application
    • Agricultural
    • Diagnostic
    • Therapeutic
      • Human Therapeutic
      • Veterinary Therapeutic
  • End-User
    • Hospitals and Clinics
    • Pharmaceutical Companies
    • Research Institutions
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of antibiotic-resistant bacterial infections driving demand for bacteriophage therapy
5.1.1.2. Rising investments in research and development for bacteriophage applications in healthcare
5.1.1.3. Growing public awareness and acceptance of bacteriophage as a viable alternative to antibiotics
5.1.1.4. Expansion of bacteriophage application in food safety and agricultural productivity enhancement
5.1.2. Restraints
5.1.2.1. Limited awareness and acceptance of bacteriophage therapy among healthcare professionals and patients
5.1.2.2. High competition from established antibiotic treatments limiting bacteriophage therapy adoption
5.1.3. Opportunities
5.1.3.1. Collaborating with pharmaceutical companies to accelerate bacteriophage drug development pipelines
5.1.3.2. Implementing bacteriophage use in veterinary medicine to improve animal health and food production
5.1.3.3. Utilizing bacteriophage therapies in combination with traditional antibiotics for synergistic effects
5.1.4. Challenges
5.1.4.1. Lack of standardized protocols for bacteriophage therapy impeding clinical adoption and consistency
5.1.4.2. High specificity of bacteriophages requiring individualized development for different bacterial strains
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Bacteriophage Market, by Type
6.1. Introduction
6.2. Lysogenic
6.3. Lytic
7. Bacteriophage Market, by Product
7.1. Introduction
7.2. Phage Diagnostic Products
7.3. Phage Research Tools
7.4. Phage Therapy Products
8. Bacteriophage Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Solid
9. Bacteriophage Market, by Delivery Mode
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Bacteriophage Market, by Application
10.1. Introduction
10.2. Agricultural
10.3. Diagnostic
10.4. Therapeutic
10.4.1. Human Therapeutic
10.4.2. Veterinary Therapeutic
11. Bacteriophage Market, by End-User
11.1. Introduction
11.2. Hospitals and Clinics
11.3. Pharmaceutical Companies
11.4. Research Institutions
12. Americas Bacteriophage Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Bacteriophage Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Bacteriophage Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BACTERIOPHAGE MARKET RESEARCH PROCESS
FIGURE 2. BACTERIOPHAGE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
FIGURE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BACTERIOPHAGE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BACTERIOPHAGE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BACTERIOPHAGE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BACTERIOPHAGE MARKET DYNAMICS
TABLE 7. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYSOGENIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LYTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE DIAGNOSTIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE RESEARCH TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHAGE THERAPY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BACTERIOPHAGE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BACTERIOPHAGE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BACTERIOPHAGE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BACTERIOPHAGE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BACTERIOPHAGE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BACTERIOPHAGE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BACTERIOPHAGE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HUMAN THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BACTERIOPHAGE MARKET SIZE, BY VETERINARY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BACTERIOPHAGE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BACTERIOPHAGE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BACTERIOPHAGE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. CANADA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 57. CANADA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 58. CANADA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. CANADA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 60. CANADA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 64. MEXICO BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 67. MEXICO BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BACTERIOPHAGE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. CHINA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. CHINA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. CHINA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 94. CHINA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 95. CHINA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. CHINA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 97. CHINA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. INDIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. INDIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. INDIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. INDIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 102. INDIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. INDIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 104. INDIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. JAPAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. JAPAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. JAPAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 115. JAPAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 116. JAPAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. JAPAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 118. JAPAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. TAIWAN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. THAILAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 155. THAILAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. THAILAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 157. THAILAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 158. THAILAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. THAILAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 160. THAILAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. VIETNAM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA BACTERIOPHAGE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 176. DENMARK BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. DENMARK BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. DENMARK BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 179. DENMARK BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 180. DENMARK BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. DENMARK BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 182. DENMARK BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. EGYPT BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. EGYPT BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. EGYPT BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 186. EGYPT BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 187. EGYPT BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. EGYPT BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 189. EGYPT BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. FINLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. FINLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 193. FINLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 194. FINLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. FINLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 196. FINLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. FRANCE BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. FRANCE BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. FRANCE BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 200. FRANCE BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 201. FRANCE BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. FRANCE BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 203. FRANCE BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. GERMANY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 207. GERMANY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 208. GERMANY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. GERMANY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 210. GERMANY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. ITALY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. ITALY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. ITALY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 221. ITALY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 222. ITALY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 223. ITALY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 224. ITALY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. NORWAY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. NORWAY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. NORWAY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. NORWAY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 245. NORWAY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. POLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 247. POLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. POLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 249. POLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 250. POLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. POLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 252. POLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. QATAR BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 254. QATAR BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. QATAR BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 256. QATAR BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 257. QATAR BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. QATAR BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 259. QATAR BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. SPAIN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 282. SPAIN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. SPAIN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 284. SPAIN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 285. SPAIN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. SPAIN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 287. SPAIN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. TURKEY BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 303. TURKEY BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 304. TURKEY BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 305. TURKEY BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 306. TURKEY BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. TURKEY BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 308. TURKEY BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM BACTERIOPHAGE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 323. BACTERIOPHAGE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 324. BACTERIOPHAGE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Bacteriophage market, which are profiled in this report, include:
  • Adaptive Phage Therapeutics
  • AmpliPhi Biosciences Corporation
  • Armata Pharmaceuticals Inc.
  • ContraFect Corporation
  • CYTOO S.A.
  • Eligo Bioscience
  • EnBiotix Inc.
  • Fixed-Phage Limited
  • Intralytix Inc.
  • iNtRON Biotechnology
  • Locus Biosciences Inc.
  • Micreos BV
  • Optipharm Co. Ltd.
  • Phage International Inc.
  • Phagelux Inc.
  • Phagomed Biopharma GmbH
  • Pherecydes Pharma
  • Phico Therapeutics Ltd.
  • Sexton Biotechnologies
  • TechnoPhage SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages198
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 50.15 Million
Forecasted Market Value ( USD ) by 2030 $ 68.35 Million
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Biochemistry, International Adaptation. Edition No. 4 - Product Image

Biochemistry, International Adaptation. Edition No. 4

  • Book
  • 1488 Pages
  • Global
Biosensors. Nanomaterials, Approaches, and Performance-Enhancement Strategies. Edition No. 1. IEEE Press Series on Sensors - Product Image

Biosensors. Nanomaterials, Approaches, and Performance-Enhancement Strategies. Edition No. 1. IEEE Press Series on Sensors

  • Book
  • 336 Pages
Laboratory Practices in Microbiology - Product Image

Laboratory Practices in Microbiology

  • Book
Current Developments in Biotechnology and Bioengineering. Environmental and Health Impact of Hospital Wastewater - Product Image

Current Developments in Biotechnology and Bioengineering. Environmental and Health Impact of Hospital Wastewater

  • Book
Principles of Medical Biochemistry. Edition No. 4 - Product Image

Principles of Medical Biochemistry. Edition No. 4

  • Book

About the Bacteriophage Market

Bacteriophages, also known as phages, are viruses that infect and replicate within bacteria. They are of great interest to the biotechnology industry due to their potential to be used as therapeutic agents against bacterial infections. Phage therapy has been used for decades in Eastern Europe and is now gaining traction in the West as an alternative to antibiotics. Phage therapy is being explored for a variety of applications, including the treatment of antibiotic-resistant infections, the prevention of biofilm formation, and the delivery of therapeutic proteins. Companies are developing phage-based products for a range of indications, including wound healing, skin care, and food safety. The bacteriophage market is expected to grow significantly in the coming years as more companies enter the space and develop new products. Companies in the market include AmpliPhi Biosciences, Intralytix, Adaptive Phage Therapeutics, and Phagelux. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.